Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2013
Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models
Jie Lin, Deepak Sampath, Michelle A Nannini, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2010
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors
Josef R Bencsik, Dengming Xiao, James F Blake, et al.
Nature Communications
|
September 21, 2018
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Tyler Risom, Ellen M Langer, Margaret P Chapman, et al.
Nature Biotechnology
|
November 19, 2021
Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning
Noah F Greenwald, Geneva Miller, Erick Moen, et al.
Cell
|
January 22, 2022
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
Tyler Risom, David R Glass, Inna Averbukh, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors
Steve Wenglowsky, Li Ren, Kateri A Ahrendt, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Nature Cancer
|
February 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Cancer Cell
|
November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Siri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Cancer Cell
|
July 11, 2023
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Siri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2013
Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models
Jie Lin, Deepak Sampath, Michelle A Nannini, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2010
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors
Josef R Bencsik, Dengming Xiao, James F Blake, et al.
Nature Communications
|
September 21, 2018
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Tyler Risom, Ellen M Langer, Margaret P Chapman, et al.
Nature Biotechnology
|
November 19, 2021
Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning
Noah F Greenwald, Geneva Miller, Erick Moen, et al.
Cell
|
January 22, 2022
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
Tyler Risom, David R Glass, Inna Averbukh, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors
Steve Wenglowsky, Li Ren, Kateri A Ahrendt, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Nature Cancer
|
February 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Cancer Cell
|
November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Siri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Cancer Cell
|
July 11, 2023
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Siri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Page
of 3